Prostatic Neoplasms
Showing 6626 - 6650 of 7,360
Atrial Fibrillation, Diet Therapy, Prostate Cancer Trial (ALA-rich diet)
Unknown status
- Atrial Fibrillation
- +2 more
- ALA-rich diet
- (no location specified)
Jun 12, 2012
Benign Prostatic Hyperplasia Trial in Austria, Italy, United States (Tadalafil, Placebo)
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Olodaterol (BI 1744), Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- Olodaterol (BI 1744)
- Placebo
-
Mobile, Alabama
- +50 more
Jun 17, 2014
Atrial Fibrillation, Stroke Trial in Worldwide (dabigatran etexilate)
Terminated
- Atrial Fibrillation
- Stroke
- dabigatran etexilate
-
La Mesa, California
- +49 more
May 8, 2014
HIV Trial in Worldwide (nevirapine IR, nevirapine XR)
Completed
- HIV Infections
- nevirapine IR
- nevirapine XR
-
Birmingham, Alabama
- +201 more
Mar 7, 2014
Cardiovascular Diseases Trial in Worldwide (Telmisartan, Combination of Telmisartan and Ramipril, Ramipril)
Pain Trial in Worldwide (OROS hydromorphone HCl, Oxycodone)
Prostate Cancer Trial in Los Angeles (SU011248)
Completed
- Prostate Cancer
-
Los Angeles, CaliforniaUniversity of California, Los Angeles, Jonsson Comprehensive Can
Jul 27, 2012
Prostate Cancer Trial in Houston (Alprostadil (E1), Papaverine, Phentolamine mesylate)
Completed
- Prostate Cancer
- Alprostadil (E1)
- +4 more
-
Houston, TexasM.D. Anderson Cancer Center at University of Texas
Jul 27, 2012
Prostate Cancer Trial in Toronto (Metformin)
Terminated
- Prostate Cancer
-
Toronto, Ontario, CanadaUniversity Health Network
Jun 18, 2012
Prostate Cancer Trial in Stanford (Taxotere)
Completed
- Prostate Cancer
-
Stanford, CaliforniaStanford University Cancer Center
Jun 12, 2012
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Olodaterol (BI 1744), Formoterol, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- Olodaterol (BI 1744)
- +2 more
-
Capital Federal, Argentina
- +92 more
Jun 17, 2014
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Olodaterol (BI 1744), Formoterol, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- Olodaterol (BI 1744)
- +2 more
-
Capital Federal, Argentina
- +97 more
Jun 17, 2014
Atrial Fibrillation Trial in Worldwide (dabigatran dose 1, dabigatran dose 2)
Completed
- Atrial Fibrillation
- dabigatran dose 1
- dabigatran dose 2
-
Birmingham, Alabama
- +566 more
Jun 3, 2014
Diabetes, Type 2 Trial in Worldwide (Placebo identical to BI 1356 5mg, Placebo identical to Glimepiride 1mg or 2mg or 3mg or 4
Completed
- Diabetes Mellitus, Type 2
- Placebo identical to BI 1356 5mg
- +3 more
-
Tempe, Arizona
- +220 more
Dec 11, 2013
Prostate Cancer Trial in Toronto (MRI Targeted Focal Thermal Therapy of Prostate Cancer)
Completed
- Prostate Cancer
- MRI Targeted Focal Thermal Therapy of Prostate Cancer
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Jun 14, 2012
Mental Health, Stress Disorders, Post-Traumatic, Substance-Related Disorders Trial in United States (Integrated Care for Smoking
Completed
- Mental Health
- +3 more
- Integrated Care for Smoking Cessation in PTSD patients
- Standard of Care
-
Tuscaloosa, Alabama
- +10 more
Apr 18, 2014
Renal Cell Carcinoma Trial in Worldwide (Sorafenib, temsirolimus (Torisel))
Completed
- Renal Cell Carcinoma
- Sorafenib
- temsirolimus (Torisel)
-
Duarte, California
- +127 more
Oct 28, 2013
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (Aliskiren, Placebo)
Terminated
- Type 2 Diabetes Mellitus
- Cardiovascular Disease
- Aliskiren
- Placebo
-
Birmingham, Alabama
- +777 more
Apr 1, 2014
Thrombosis Trial in Istanbul
Completed
- Thrombosis
-
Istanbul, TurkeyIstanbul University Cerrahpasa Medical Faculty
Jun 14, 2013
COPD Trial in Worldwide (Indacaterol 150 µg, Tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- Indacaterol 150 µg
- Tiotropium
-
Capital Federal, Buenos Aires, Argentina
- +423 more
Sep 16, 2013